• Split Dosing of Darzalex Over Consecutive Days Approved by FDA for Multiple Myeloma Patients
  • $75M Gift to Establish Center for Blood Cancers at NYU Langone Health Center
  • Real-world Data Supports Use of Oral Triple Combination in Treating Advanced Multiple Myeloma, Study Finds
  • Isatuximab Extends Time Without Cancer Progression in Phase 3 Trial of Multiple Myeloma
  • Thalidomide at 100 mg Shows Benefits as Maintenance Therapy in Multiple Myeloma Patients in Trial
  • Donation Will Establish Center for Multiple Myeloma Research in UK
  • Measuring Blood Vessel Activity May Predict Multiple Myeloma Prognosis
  • Single-cell Profiling in Multiple Myeloma May Improve Diagnosis, Treatment, Study Suggests
  • clonoSEQ Assay Now Covered by Medicare for Multiple Myeloma and Acute Lymphoblastic Leukemia
  • FDA Asked to OK Darzalex as Combo Therapy for Newly Diagnosed Group of Multiple Myeloma Patients
  • Recruitment Begins in Phase 1 Trial of C-CAR088 for Multiple Myeloma
  • CLR 131 Significantly Extends Survival of Heavily Treated Multiple Myeloma Patients in Phase 1 Trial